Analyzing Generics Market in Canada 2017

  • ID: 4382493
  • Report
  • Region: Canada
  • 90 Pages
  • Aruvian's R'search
1 of 5

FEATURED COMPANIES

  • Allergan Plc
  • Apotex Inc.
  • Lupin Limited
  • Mylan N.V.
  • Sandoz International GmbH
  • Sanofi SA
  • MORE

Globalization in pharmaceutical supply chains has changed how generic drug manufacturers are operating and competing globally. There has been a marked decrease in the time to market for generic drugs as well as an increase in the availability, variety and number of generic drugs available on the global market. The face of the Canadian generic market has changed rapidly over the last couple of years, marked by mergers and acquisitions. The regulatory framework in Canada remains more focused on ensuring patent safety and product quality within the market, thus hindering the fulfillment of benefits from the globalization of supply chains within Canada.

The Canadian generics market was worth over USD 4 billion in 2016 and is not expected to post significant growth in the coming years. In fact, the market is expected to barely cross a value of USD 5 billion by the end of 2021.

Analyzing Generics Market in Canada 2017 - a comprehensive coverage of the Canadian generic drugs market. Beginning with a sectional description on the global generic industry, the report looks at an overview of the industry, an analysis of the market volume and value, industry segmentation and an industry forecast.

The Generics Industry in Canada is analyzed through an industry overview which spans the data from 2012 till 2021. An analysis of the industry's value and volume data is included along with an industry segmentation by geography. Industry forecast of the industry is also included.

We also include a Porter’s Five Forces analysis of the Canadian Generics Industry.

Analysis of the major industry players in the Canadian generics market are analyzed through an analysis of their business segments, a financial analysis and a SWOT analysis. Players analyzed include Mylan, Lupin Pharma Canada, Sanofi, Teva and others. This concludes this comprehensive research report Research.

This research report helps you get an insider’s look at the Canadian generic industry and helps you understand what the future holds for the industry. Regulatory framework, pricing and reimbursement scenarios, comparison of the Canadian market with its regional counterparts, all these data points makes this report an essential resource for analytical purposes.

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Allergan Plc
  • Apotex Inc.
  • Lupin Limited
  • Mylan N.V.
  • Sandoz International GmbH
  • Sanofi SA
  • MORE

A. Executive Summary

B. Analyzing the Global Generics Industry
B.1 Industry Definition
B.2 Industry Overview
B.3 Industry Value & Volume Analysis
B.4 Industry Segmentation by Geography
B.5 Patent Expiries
B.6 Global Generic Industry Structure
B.7 Industry Forecast

C. Generics Industry in Canada
C.1 Industry Overview
C.2 Industry Value & Volume
C.3 Industry Segmentation by Geography
C.4 Industry Forecast

D. Generics Industry in Canada: Porter’s Five Forces Strategy Analysis
D.1 Introduction
D.2 Bargaining Power of Buyers
D.3 Bargaining Power of Suppliers
D.4 Competitive Rivalry in the Industry
D.5 Threat of New Entrants
D.6 Threat of Substitutes

E. Major Industry Players
E.1 Allergan Plc
E.1.1 Corporate Analysis
E.1.2 Financial Analysis
E.1.3 SWOT Analysis
E.2 Apotex Inc.
E.2.1 Corporate Analysis
E.2.2 Financial Analysis
E.2.3 SWOT Analysis
E.3 Lupin Limited
E.3.1 Corporate Analysis
E.3.2 Financial Analysis
E.3.3 SWOT Analysis
E.4 Mylan N.V.
E.4.1 Corporate Analysis
E.4.2 Financial Analysis
E.4.3 SWOT Analysis
E.5 Sanofi SA
E.5.1 Corporate Analysis
E.5.2 Financial Analysis
E.5.3 SWOT Analysis
E.6 Teva Pharmaceutical Industries Limited
E.6.1 Corporate Analysis
E.6.2 Financial Analysis
E.6.3 SWOT Analysis
E.7 Sandoz International GmbH

F. Glossary of Terms

List of Figures
Figure 1: Historical Revenues of Leading Generic Companies (in USD Million), 2008-2009
Figure 2: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Figure 3: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Figure 4: Global Generics Market Segmentation by Geography (%), 2016
Figure 5: Revenues of Top 10 Drugs that went off Patent between 2010-2014 (in USD Million)
Figure 6: Market Share of Leading Generic Companies Worldwide (%), 2016
Figure 7: Comparison of Revenues of Leading Generic Companies (in USD Million), 2013-2014
Figure 8: Global Generics Industry Forecast (in USD Billion), 2016-2021
Figure 9: Global Generics Industry Forecast by Volume (% of Pharma Volume), 2016-2021
Figure 10: Value of the Generics Market in Canada (in USD Billion), 2012-2016
Figure 11: Volume Growth of the Generics Market in Canada (%), 2012-2016
Figure 12: Share of Canada in the Americas Generics Industry (%), 2016
Figure 13: Forecast of the Generics Market in Canada (in USD Billion), 2016-2021
Figure 14: Volume Forecast of the Generics Market in Canada (%), 2016-2021
Figure 15: Porter's Five Forces Strategy Analysis of the Generics Industry in Canada
Figure 16: Bargaining Power of Buyers in the Canadian Generics Industry
Figure 17: Bargaining Power of Suppliers in the Canadian Generics Industry
Figure 18: Competitive Rivalry in the Canadian Generics Industry
Figure 19: Threat of New Entrants to the Canadian Generics Industry
Figure 20: Threat of Substitutes to the Canadian Generics Industry
Figure 21: Revenues & Profitability of Allergan Plc (in USD Million), 2011-2015
Figure 22: Revenues & Profitability of Lupin (in USD Million), 2011-2015
Figure 23: Revenues & Profitability of Sanofi SA (in USD Million), 2011-2015
Figure 24: Revenues & Profitability of Teva Pharmaceutical (in USD Million), 2011-2015

List of Tables
Table 1: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Table 2: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Table 3: Global Generics Industry, Segmentation by Geography (in USD Billion), 2016
Table 4: Global Generics Industry Forecast (in USD Billion), 2016-2021
Table 5: Global Generics Industry Forecast by Volume & Percentage Growth (% of Pharma Volume), 2016-2021
Table 6: Value of the Generics Market in Canada (in USD Billion), 2012-2016
Table 7: Volume Growth of the Generics Market in Canada (%), 2012-2016
Table 8: Share of Canada in the Americas Generics Industry (% & USD Billion), 2016
Table 9: Forecast of the Generics Market in Canada (in USD Billion), 2016-2021
Table 10: Volume Forecast of the Generics Market in Canada (%), 2016-2021
Table 11: Key Financials of Allergan Plc (in USD Million), 2011-2015
Table 12: Key Financials of Lupin (in USD Million), 2011-2015
Table 13: Key Financials of Sanofi SA (in USD Million), 2011-2015
Table 14: Key Financials of Teva Pharmaceutical (in USD Million), 2011-2015

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Allergan Plc
  • Apotex Inc.
  • Lupin Limited
  • Mylan N.V.
  • Sandoz International GmbH
  • Sanofi SA
  • Teva Pharmaceutical Industries Limited
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll